Excessive Catecholamine Secretion and the Activation of the Renin-Angiotensin-Aldosterone-System in Patients with Pheochromocytoma: A Single Center Experience and Overview of the Literature.
Haase M, Dringenberg T, Allelein S, Willenberg HS, Schott M.
Horm Metab Res. 2017 Oct;49(10):748-754. doi: 10.1055/s-0043-117179. Epub 2017 Aug 24.
Preoperative Management of Pheochromocytoma and Paraganglioma.
Fang F, Ding L, He Q, Liu M.
Front Endocrinol (Lausanne). 2020 Sep 29;11:586795. doi: 10.3389/fendo.2020.586795. eCollection 2020.
Pheochromocytoma/paraganglioma-associated cardiomyopathy.
Szatko A, Glinicki P, Gietka-Czernel M.
Front Endocrinol (Lausanne). 2023 Jul 13;14:1204851. doi: 10.3389/fendo.2023.1204851. eCollection 2023.
Adapting to obesity with adipose tissue inflammation.
Reilly SM, Saltiel AR.
Nat Rev Endocrinol. 2017 Nov;13(11):633-643. doi: 10.1038/nrendo.2017.90. Epub 2017 Aug 11.
Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A, Baracco R, Kapur G.
Pediatr Nephrol. 2020 Apr;35(4):581-594. doi: 10.1007/s00467-018-4181-2. Epub 2019 Jan 2.
Subclinical phaeochromocytoma.
Mannelli M, Lenders JW, Pacak K, Parenti G, Eisenhofer G.
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):507-15. doi: 10.1016/j.beem.2011.10.008. Epub 2012 May 22.
Takotsubo syndrome: getting closer to its causes.
Akhtar MM, Cammann VL, Templin C, Ghadri JR, Lüscher TF.
Cardiovasc Res. 2023 Jul 4;119(7):1480-1494. doi: 10.1093/cvr/cvad053.
Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells.
Streit L, Moog S, Hugel S, Rame M, Tanguy E, Andry V, Schmid HA, Brunaud L, Bihain F, Nominé-Criqui C, Goumon Y, Lacomme S, Lomazzi S, Vix M, Mutter D, Vitale N, Ory S, Gasman S.
Cancer Lett. 2022 Jan 1;524:232-244. doi: 10.1016/j.canlet.2021.10.009. Epub 2021 Oct 9.
Ferroptosis contributes to catecholamine-induced cardiotoxicity and pathological remodeling.
Chen Y, Guo X, Zeng Y, Mo X, Hong S, He H, Li J, Steinmetz R, Liu Q.
Free Radic Biol Med. 2023 Oct;207:227-238. doi: 10.1016/j.freeradbiomed.2023.07.025. Epub 2023 Jul 25.
Catecholamine-induced cardiomyopathy: an endocrinologist's perspective.
Kumar A, Pappachan JM, Fernandez CJ.
Rev Cardiovasc Med. 2021 Dec 22;22(4):1215-1228. doi: 10.31083/j.rcm2204130.
